Merck Research and Development Expenses 2010-2024 | MKKGY
Merck annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Merck research and development expenses for the quarter ending June 30, 2024 were $0.697B, a 6.5% increase year-over-year.
- Merck research and development expenses for the twelve months ending June 30, 2024 were $2.679B, a 0.89% increase year-over-year.
- Merck annual research and development expenses for 2023 were $2.646B, a 0.37% decline from 2022.
- Merck annual research and development expenses for 2022 were $2.656B, a 6.77% decline from 2021.
- Merck annual research and development expenses for 2021 were $2.849B, a 9% increase from 2020.
Merck Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$2,646 |
| 2022 |
$2,656 |
| 2021 |
$2,849 |
| 2020 |
$2,614 |
| 2019 |
$2,540 |
| 2018 |
$2,628 |
| 2017 |
$2,419 |
| 2016 |
$2,187 |
| 2015 |
$1,897 |
| 2014 |
$2,265 |
| 2013 |
$1,998 |
| 2012 |
$1,944 |
| 2011 |
$2,113 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-06-30 |
$697 |
| 2024-03-31 |
$631 |
| 2023-12-31 |
$719 |
| 2023-09-30 |
$632 |
| 2023-06-30 |
$654 |
| 2023-03-31 |
$641 |
| 2022-12-31 |
$713 |
| 2022-09-30 |
$647 |
| 2022-06-30 |
$639 |
| 2022-03-31 |
$658 |
| 2021-12-31 |
$674 |
| 2021-09-30 |
$778 |
| 2021-06-30 |
$705 |
| 2021-03-31 |
$692 |
| 2020-12-31 |
$782 |
| 2020-09-30 |
$621 |
| 2020-06-30 |
$573 |
| 2020-03-31 |
$639 |
| 2019-12-31 |
$699 |
| 2019-09-30 |
$620 |
| 2019-06-30 |
$622 |
| 2019-03-31 |
$599 |
| 2018-12-31 |
$724 |
| 2018-09-30 |
$630 |
| 2018-06-30 |
$642 |
| 2018-03-31 |
$632 |
| 2017-12-31 |
$678 |
| 2017-09-30 |
$641 |
| 2017-06-30 |
$573 |
| 2017-03-31 |
$528 |
| 2016-12-31 |
$591 |
| 2016-09-30 |
$494 |
| 2016-06-30 |
$561 |
| 2016-03-31 |
$539 |
| 2015-12-31 |
$430 |
| 2015-09-30 |
$464 |
| 2015-06-30 |
$504 |
| 2015-03-31 |
$498 |
| 2014-12-31 |
$536 |
| 2014-09-30 |
$668 |
| 2014-06-30 |
$541 |
| 2014-03-31 |
$519 |
| 2013-12-31 |
$471 |
| 2013-09-30 |
$502 |
| 2013-06-30 |
$488 |
| 2013-03-31 |
$537 |
| 2012-12-31 |
|
| 2012-09-30 |
$464 |
| 2012-06-30 |
$519 |
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
$531 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$450 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
